Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study (Q34553531)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

Crohn's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

T A Winter

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

J Wright

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

S Ghosh

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

J Jahnsen

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

A Innes

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

P Round

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

11-12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1337-1346

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

Management of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

Management of Crohn's disease in adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02285.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2004.02285.X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34553531&oldid=1694233107"